Evidence map›Paper›PMID 39955388›Full record

ArticleCommunications biology2025

KDM5C and KDM5D mutations have different consequences in clear cell renal cell carcinoma cells.

Marvin Müller, Kyra Zodel, Behnaz A Abhari, Francesca Cuomo, Sheikh Nizamuddin, Patrick Metzger, Melanie Boerries, H T Marc Timmers, Ian J Frew

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marvin Müller *Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
Kyra Zodel *Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0002-6581-3972
Behnaz A Abhari *Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
Francesca Cuomo *Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
Sheikh NizamuddinDepartment of Urology, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
Patrick MetzgerInstitute of Medical Bioinformatics and Systems Medicine, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0002-2451-1943
Melanie BoerriesInstitute of Medical Bioinformatics and Systems Medicine, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0002-3670-0602
H T Marc TimmersDepartment of Urology, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
Ian J FrewDepartment of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany. ian.frew@uniklinik-freiburg.de.ORCID http://orcid.org/0000-0003-2735-5509

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 42490703Deutsche Forschungsgemeinschaft (German Research Foundation) 431984000Deutsche Forschungsgemeinschaft (German Research Foundation) 441891347Deutsche Forschungsgemeinschaft (German Research Foundation) 493802833
6 · The paper itself

Abstract

KDM5C is commonly mutated in clear cell renal cell carcinomas (ccRCC) in men but rarely in women. Introducing KDM5C mutation into two male and two female KDM5C wild-type ccRCC cell lines caused different phenotypes and non-overlapping transcriptional consequences, indicative of context-dependent functions of KDM5C. We identify that loss of the Y chromosome, harbouring the KDM5C homologue KDM5D, occurs in most male KDM5C mutant ccRCCs. Mutation of KDM5D in male 786-O cells prevented xenograft tumour formation and this phenotype was unexpectedly rescued by co-mutation of KDM5C, consistent with the co-occurrence of KDM5C mutation and loss of the Y chromosome in ccRCC. Transcriptional analyses showed that KDM5C and KDM5D regulate the expression of both overlapping as well as distinct sets of genes. While KDM5C and KDM5D bind to at least some overlapping genomic sites, gene expression changes induced by KDM5C or KDM5D mutation are apparently unrelated to the direct functions of these proteins at the relevant gene promoters or enhancers. Our findings identify similarities and differences in KDM5C and KDM5D functions, challenging the idea that KDM5D in male cells functions equivalently to the second KDM5C allele in female cells, and implicate an interplay between KDM5C mutation and Y chromosome loss in ccRCC development in men.

Indexed as

Carcinoma, Renal CellHistone DemethylasesKidney NeoplasmsMutationAnimalsCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansMaleMiceMinor Histocompatibility AntigensHistone DemethylasesKDM5C protein, humanKDM5D protein, humanMinor Histocompatibility Antigens

Identifiers

PMID39955388
PMCPMC11830100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.